Generate Biomedicines plans up to $425 million U.S. IPO
Go back to Generate Biomedicines plans up to $425 million U.S. IPO| (NASDAQ: GENB) | Delayed: 15.81 +0.54 (3.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.27 | 52 Week High | $ | |||
| Open | $15.12 | 52 Week Low | $ | |||
| Day High | $15.93 | P/E | N/A | |||
| Day Low | $14.93 | EPS | $ | |||
| Volume | 671,358 | |||||

